Appendage closure devices have emerged as an alternative to anticoagulation in fibrillated patients with a contraindication for it. The study included 63 patients with paroxysmal, persistent or permanent FA coupled with a CHADS score >1 and eligible to interrupt anticoagulation. The primary endpoint was atrial appendage occlusion evaluated by ultrasound between 45 and 180 days after. After 45 days, 97% of patients had the right atrial appendage occluded and none had adverse events.
Conclusion: This new device seems easy to use and safe, with a 97% success rate in the implant and 97% occlusion of the atrial appendage at 45 days.
Richard Heuser
2013-05-23
Original title: Left atrial appendage closure with the Coherex Wave Crest left atrial appendage closure device.